Efficacy Evaluation of Meloxicam 15mg Tablet through Bioequivalence Study in Indonesian Healthy Volunteers

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2024, Vol 8, Issue 1

Abstract

Objective: The objective of this study is to compare the efficacy between the generic drug of Meloxicam 15mg Tablets produced by PT. Kimia Farma Tbk and its comparator (Movi-Cox® 15mg Tablet by PT. Boehringer Ingelheim Indonesia) by a study of bioequivalence in Indonesian healthy volunteers Methods: A randomized, single-dose, open-label, crossover two-way (2 treatments, 2 periods, and 2 sequences) under fasting condition were conducted in healthy Indonesian volunteers to evaluate bioequivalence between 2 formulations of Meloxicam 15mg tablet. This study required washout period of at least 7-days. The test and comparator drug were administered to subjects as a single oral dose. Blood samples were collected adequately (0–72 h) with 18 points to determine meloxicam concentrations in plasma using a validated LC-MS/MS analytical method. The number of subjects who participated and completed the study were 18 volunteer (9 male and 9 female). The pharmacokinetic parameters calculated in this study are AUC0-72, AUC0-inf, Cmax, tmax, and t½. The bioequivalence acceptance limit of 90% confidence interval (CI) with α = 5.00% is 80.00–125.00% for AUC and Cmax parameters. The estimation of Tmax and T½ in the bioequivalence study was based on a nonparametric statistical procedure on the original data using Wilcoxon Sign Test. Result: The results for AUC0-72 and Cmax were 108.07% (104.88-111.35) % and 105.24% (97.72-113.34) % respectively with intra-subject variability (%CV) was 5.15% for AUC0-t and 12.80% for Cmax. These results were within the regulatory acceptance limit 80.00-125.00%. Conclusion: Based on this result, it was concluded that the test formulation is bioequivalent to comparator formulation.

Authors and Affiliations

Priyanto*, Widiastuti E, Wahyono BH, Susilo MJ, Yunica NT, Bachtiar LNW, Anindyani SA, Azzaera AH and Wahyuningsih R

Keywords

Related Articles

Evaluation of Anti-Diarrheal Potential of Clerodendrum Wallichii (Merr.) Leaves

Clerodendrum wallichii Merr. (Family: Lamiaceae) commonly known as Sampulis is native to southern Asia from the Himalayas to Southern China. In India, it is found in Sikkim, Tripura, Mizoram, Meghalaya, Assam, Maharashtr...

Herbal Sunscreens and Photo Protection Compositions: A Patent Review

Solar ultraviolet type B radiations (UVB) is fundamentally liable to be absorbed by keratinocytes leading to production of free radicals or reactive oxygen species (ROS) which might cause skin erythema, sunburn, skin can...

Marine Algae as a Precursor for Eco-Friendly Synthesis of Nanoparticles

In the last decade, researchers were developing different types of nanoparticles and exploring more and more applications that made this area of research so promising and very active. Actually, many techniques can be fo...

Nanotechnology Integration in Education: Challenges, Strategies and Prospects

Nanotechnology is a rapidly evolving interdisciplinary field with vast potential applications across various sectors, including medicine, electronics, and energy. Its integration into education presents both opportuniti...

Application of Plant Based Natural Polymer in Drug Delivery System: A Critical Overview

Several natural polymers have been used for a variety of biomedical applications including drug targeting, pharmaceutical preparations, drug delivery systems, prosthetics, and tissue engineering scaffolds. Natural polym...

Download PDF file
  • EP ID EP751874
  • DOI 10.23880/oajpr-16000304
  • Views 27
  • Downloads 0

How To Cite

Priyanto*, Widiastuti E, Wahyono BH, Susilo MJ, Yunica NT, Bachtiar LNW, Anindyani SA, Azzaera AH and Wahyuningsih R (2024). Efficacy Evaluation of Meloxicam 15mg Tablet through Bioequivalence Study in Indonesian Healthy Volunteers. Open Access Journal of Pharmaceutical Research, 8(1), -. https://europub.co.uk/articles/-A-751874